Growth Metrics

Scholar Rock Holding (SRRK) Cash & Current Investments (2017 - 2026)

Scholar Rock Holding's quarterly Cash & Current Investments came in at $479.9 million in Q1 2026, up 31.72% year-on-year from $364.4 million in Q1 2025, and up 30.57% quarter-over-quarter from $367.6 million in Q4 2025.

Scholar Rock Holding has reported Cash & Current Investments for 10 years, with the latest figure at $479.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments rose 31.72% year-over-year to $479.9 million; the trailing twelve-month figure through Mar 2026 stood at $479.9 million (up 31.72% YoY), and the FY2025 full-year result was $367.6 million, down 15.94% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $479.9 million, up from $367.6 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $479.9 million in Q1 2026, with the low at $139.1 million in Q3 2024.
  • Average Cash & Current Investments over 5 years is $302.6 million, with a median of $295.0 million recorded in 2025.
  • Year-over-year, Cash & Current Investments sank 36.39% in 2024 and surged 165.8% in 2025.
  • Tracing SRRK's Cash & Current Investments over 5 years: stood at $315.4 million in 2022, then slipped by 11.23% to $279.9 million in 2023, then soared by 56.21% to $437.3 million in 2024, then decreased by 15.94% to $367.6 million in 2025, then surged by 30.57% to $479.9 million in 2026.
  • The last three Cash & Current Investments figures came in at $479.9 million (Q1 2026), $367.6 million (Q4 2025), and $369.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.13 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 32.30 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 61.46 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.25 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 8.75 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.01 Bn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - 479.94 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 479.94 Mn
Dec 31, 2025 367.56 Mn
Sep 30, 2025 369.63 Mn
Jun 30, 2025 295.01 Mn
Mar 31, 2025 364.38 Mn
Dec 31, 2024 437.28 Mn
Sep 30, 2024 139.07 Mn
Jun 30, 2024 190.49 Mn
Mar 31, 2024 238.43 Mn
Dec 31, 2023 279.94 Mn
Sep 30, 2023 218.64 Mn
Jun 30, 2023 248.73 Mn
Mar 31, 2023 275.28 Mn
Dec 31, 2022 315.36 Mn
Sep 30, 2022 343.66 Mn
Jun 30, 2022 370.69 Mn
Mar 31, 2022 210.21 Mn
Dec 31, 2021 252.99 Mn
Sep 30, 2021 246.44 Mn
Jun 30, 2021 282.22 Mn
Mar 31, 2021 314.69 Mn
Dec 31, 2020 341.03 Mn
Sep 30, 2020 116.26 Mn
Jun 30, 2020 141.18 Mn
Mar 31, 2020 160.65 Mn
Dec 31, 2019 157.45 Mn
Sep 30, 2019 176.08 Mn
Jun 30, 2019 185.13 Mn
Mar 31, 2019 159.67 Mn
Dec 31, 2018 175.65 Mn
Sep 30, 2018 103.99 Mn
Jun 30, 2018 115.06 Mn
Dec 31, 2017 57.96 Mn